Fatigue Item Response among Hemoglobin-Normalized Patients with Paroxysmal Nocturnal Hemoglobinuria: PEGASUS Trial Results at 16 and 48 Weeks
<b>Background.</b> A common symptom of paroxysmal nocturnal hemoglobinuria (PNH) is fatigue, which in some patients can be severe. Eculizumab (Ecu) has proven efficacy in controlling intravascular hemolysis, but commonly results in persistent anemia and fatigue. Pegcetacoplan’s (Peg) eff...
Main Authors: | Carolyn E. Schwartz, Katrina Borowiec, Jinny Min, Jesse Fishman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/13/6/1703 |
Similar Items
-
Paroxysmal Nocturnal Hemoglobinuria: Biology and Treatment
by: Carlos Bravo-Perez, et al.
Published: (2023-09-01) -
Paroxysmal nocturnal hemoglobinuria in the differential diagnosis of thrombocytopenia
by: Fusun Gediz, et al.
Published: (2017-03-01) -
Treatment of paroxysmal nocturnal hemoglobinuria
by: I. A. Lisukov, et al.
Published: (2014-07-01) -
Treatment of paroxysmal nocturnal hemoglobinuria
by: I. A. Lisukov, et al.
Published: (2014-07-01) -
Frequency of Paroxysmal Nocturnal Hemoglobinuria Clone in Turkish Myelodysplastic Syndrome Group
by: Mesut Ayer, et al.
Published: (2018-09-01)